Microchimerism in scleroderma: Ten years later;Microchimérisme dans la sclérodermie: Dix ans après

Revue de Medecine Interne

Volumn 31, Issue 7, 2010, Pages 523-529

  Lambert, N C ^a  

^a INSERM   (France)

Author keywords

Autoimmunity; Microchimerism; Systemic sclerosis

Indexed keywords

ALLOIMMUNITY; AUTOIMMUNITY; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYPOTHESIS; IMMUNOREACTIVITY; MICROCHIMERISM; PHENOTYPE; SCLERODERMA; SHORT SURVEY; SYSTEMIC SCLEROSIS; CHIMERA; GENETICS; MEDICAL RESEARCH; TIME;

BIOMEDICAL RESEARCH; CHIMERISM; HUMANS; SCLERODERMA, SYSTEMIC; TIME FACTORS;

EID: 77953961462     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.07.017     Document Type: Short Survey

References (57)

1. Lo Y.M., Lo E.S., Watson N., Noakes L., Sargent I.L., Thilaganathan B., et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996, 88:4390-4395.
2. Thomas M.R., Williamson R., Craft I., Yazdani N., Rodeck C.H. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 1994, 343:413-414.
3. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996, 93:705-708.
4. Yan Z., Lambert N.C., Guthrie K.A., Porter A.J., Loubiere L.S., Madeleine M.M., et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005, 118:899-906.
5. Hall J.M., Lingenfelter P., Adams S.L., Lasser D., Hansen J.A., Bean M.A. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 1995, 86:2829-2832.
6. Pollack M.S., Kapoor N., Sorell M., Kim S.J., Christiansen F.T., Silver D.M., et al. DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation 1980, 30:331-334.
7. Vabres P., Malinge M.C., Larregue M., Bonneau D. Microchimerism from a dizygotic twin in juvenile ulcerative lichen planus. Lancet 2002, 359:1861-1862.
8. Stevens A.M., Hermes H.M., Lambert N.C., Nelson J.L., Meroni P.L., Cimaz R. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology 2005, 44:187-191.
9. Lambert N.C., Pang J.M., Yan Z., Erickson T.D., Stevens A.M., Furst D.E., et al. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005, 64:845-848.
10. Lee T.H., Paglieroni T., Ohto H., Holland P.V., Busch M.P. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999, 93:3127-3139.
11. Nelson J.L. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune?. Arthritis Rheum 1996, 39:191-194.
12. Nelson J.L., Furst D.E., Maloney S., Gooley T., Evans P.C., Smith A., et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559-562.
13. Lambert N.C., Reed A.M. Maternal-fetal aspects of autoimmune diseases. Reproductive and hormonal aspect of systemic autoimmune disease 2005, Elsevier. M. Lockshin, W. Branch (Eds.).
14. Artlett C.M., Smith J.B., Jimenez S.A. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998, 338:1186-1191.
15. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
16. Maloney S., Smith A., Furst D.E., Myerson D., Rupert K., Evans P.C., et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999, 104:41-47.
17. Murata H., Nakauchi H., Sumida T. Microchimerism in Japanese women patients with systemic sclerosis. Lancet 1999, 354:220.
18. Lambert N.C., Evans P.C., Hashizumi T.L., Maloney S., Gooley T., Furst D.E., et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J Immunol 2000, 164:5545-5548.
19. Miyashita Y., Ono M., Ueki H., Kurasawa K. Y chromosome microchimerism in rheumatic autoimmune disease. Ann Rheum Dis 2000, 59:655-656.
20. Artlett C.M., Cox L.A., Jimenez S.A. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens. Arthritis Rheum 2000, 43:1062-1067.
21. Johnson K.L., Nelson J.L., Furst D.E., McSweeney P.A., Roberts D.J., Zhen D.K., et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 2001, 44:1848-1854.
22. Ohtsuka T., Miyamoto Y., Yamakage A., Yamazaki S. Quantitative analysis of microchimerism in systemic sclerosis skin tissue. Arch Dermatol Res 2001, 293:387-391.
23. Scaletti C., Vultaggio A., Bonifacio S., Emmi L., Torricelli F., Maggi E., et al. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002, 46:445-450.
24. Aractingi S., Regnier S. Microchimerisme in systemic sclerosis. Ann Med Interne (Paris) 2002, 153:189-191.
25. Artlett C.M., Cox L.A., Ramos R.C., Dennis T.N., Fortunato R.A., Hummers L.K., et al. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin Immunol 2002, 103:303-308.
26. Lambert N.C., Lo Y.M., Erickson T.D., Tylee T.S., Guthrie K.A., Furst D.E., et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002, 100:2845-2851.
27. Gannage M., Amoura Z., Lantz O., Piette J.C., Caillat-Zucman S. Feto-maternal microchimerism in connective tissue diseases. Eur J Immunol 2002, 32:3405-3413.
28. Burastero S.E., Galbiati S., Vassallo A., Sabbadini M.G., Bellone M., Marchionni L., et al. Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis. Arthritis Rheum 2003, 48:1109-1116.
29. Artlett C.M., O'Hanlon T.P., Lopez A.M., Song Y.W., Miller F.W., Rider L.G. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum 2003, 48:2567-2572.
30. Selva-O'Callaghan A., Mijares-Boeckh-Behrens T., Prades E.B., Solans-Laque R., Simeon-Aznar C.P., Fonollosa-Pla V., et al. Lack of evidence of foetal microchimerism in female Spanish patients with systemic sclerosis. Lupus 2003, 12:15-20.
31. Sawaya H.H., Jimenez S.A., Artlett C.M. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis. Rheumatology (Oxford) 2004, 43:965-968.
32. Lambert N.C., Erickson T.D., Yan Z., Pang J.M., Guthrie K.A., Furst D.E., et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction - Studies of healthy women and women with scleroderma. Arthritis Rheum 2004, 50:906-914.
33. Rak J.M., Pagni P.P., Tiev K., Allanore Y., Farge D., Harle J.R., et al. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset. Rheumatology 2009, 48:363-366.
34. Nakagome Y., Nagafuchi S., Nakahori Y. Prenatal sex determination. Lancet 1990, 335:291.
35. Nakagome Y., Nagafuchi S., Seki S., Nakahori Y., Tamura T., Yamada M., et al. A repeating unit of the DYZ1 family on the human Y chromosome consists of segments with partial male-specificity. Cytogenet Cell Genet 1991, 56:74-77.
36. Vodicka R., Vrtel R., Dusek L., Singh A.R., Krizova K., Svacinova V., et al. TSPY gene copy number as a potential new risk factor for male infertility. Reprod Biomed Online 2007, 14:579-587.
37. Lo Y.M., Lau T.K., Chan L.Y., Leung T.N., Chang A.M. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 2000, 46:1301-1309.
38. Pujal J.M., Gallardo D. PCR-based methodology for molecular microchimerism detection and quantification. Exp Biol Med 2008, 233:1161-1170.
39. Woo P.C., Lo S.K., Yuen K.Y., Peiris J.S., Siau H., Chiu E.K., et al. Detection of CMV DNA in bone marrow transplant recipients: plasma versus leucocyte polymerase chain reaction. J Clin Pathol 1997, 50:231-235.
40. Allanore Y, Cabane J, Mouthon L. Sclérodermies. In: Med-line, editor. Classification et évaluation des sclérodermies. Paris 2007.
41. Chiu R.W., Poon L.L., Lau T.K., Leung T.N., Wong E.M., Lo Y.M. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001, 47:1607-1613.
42. van Wijk I.J., de Hoon A.C., Jurhawan R., Tjoa M.L., Griffioen S., Mulders M.A., et al. Detection of apoptotic fetal cells in plasma of pregnant women. Clin Chem 2000, 46:729-731.
43. Wilborn F., Schmidt C.A., Siegert W. Demonstration of chimerism after allogeneic bone marrow transplantation by polymerase chain reaction of Y-chromosome-specific nucleotide sequences--characterization of a new technical approach. Leukemia 1993, 7:140-143.
44. Rak J.M., Maestroni L., Balandraud N., Guis S., Boudinet H., Guzian M.C., et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009, 60:73-80.
45. McSherry C., Jackson A., Hertz M.I., Bolman R.M., Savik K., Reinsmoen N.L. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. Transplantation 1996, 62:1811-1818.
46. Lambert N.M., Hashizumi S., Furst T., Ober D.E., Nelson C.J.L. Transgenerational microchimerism HLA-compatibility and risk of systemic sclerosis. Arthritis Rheum 1999, 42:S225.
47. Lio D., Candore G., Romano G.C., D'Anna C., Gervasi F., Di Lorenzo G., et al. Modification of cytokine patterns in subjects bearing the HLA-B8 DR3 phenotype: implications for autoimmunity. Cytokines Cell Mol Ther 1997, 3:217-224.
48. Stassi G., Todaro M., De Maria R., Candore G., Cigna D., Caruso C., et al. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8 DR3-positive individuals. Hum Immunol 1997, 55:39-45.
49. Lambert N.C., Distler O., Muller-Ladner U., Tylee T.S., Furst D.E., Nelson J.L. HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men. Arthritis Rheum 2000, 43:2005-2010.
50. Arnett F.C., Gourh P., Shete S., Ahn C.W., Honey R., Agarwal S.K., et al. Major histocompatibility complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2009.
51. Dubernard G., Oster M., Chareyre F., Antoine M., Rouzier R., Uzan S., et al. Increased fetal cell microchimerism in high grade breast carcinomas occurring during pregnancy. Int J Cancer 2009, 124:1054-1059.
52. McNallan K.T., Aponte C., El-Azhary R., Mason T., Nelson A.M., Paat J.J., et al. Immunophenotyping of chimeric cells in localized scleroderma. Rheumatology (Oxford) 2007, 46:398-402.
53. Lambert N.C. Microchimeric cells: guardians or actors of immunity in scleroderma?. Rheumatology 2007, 46:382-383.
54. Nelson J.L., Gillespie K.M., Lambert N.C., Stevens A.M., Loubiere L.S., Rutledge J.C., et al. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A 2007, 104:1637-1642.
55. Stevens A.M., Hermes H.M., Rutledge J.C., Buyon J.P., Nelson J.L. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 2003, 362:1617-1623.
56. Lambert N., Nelson J.L. Microchimerism in autoimmune disease: more questions than answers?. Autoimmun Rev 2003, 2:133-139.
57. O'Donoghue K., Chan J., de la Fuente J., Kennea N., Sandison A., Anderson J.R., et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 2004, 364:179-182.